ChemicalBook > CAS DataBase List > MDA 19
MDA 19
- Product Name
- MDA 19
- CAS No.
- 1048973-47-2
- Chemical Name
- MDA 19
- Synonyms
- MDA 19;MDA19; MDA-19;N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide;(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide;N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide;Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide
- CBNumber
- CB12535682
- Molecular Formula
- C21H23N3O2
- Formula Weight
- 349.43
- MOL File
- 1048973-47-2.mol
More
Less
MDA 19 Property
- Density
- 1.16±0.1 g/cm3 (20 ºC 760 Torr)
- storage temp.
- Store at -20°C
- solubility
- DMF: 20 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml; Methanol: 1 mg/ml
- form
- A crystalline solid
- pka
- 10.45±0.20(Predicted)
- color
- Light yellow to yellow
More
Less
N-Bromosuccinimide Price
Cayman Chemical
- Product number
- 10563
- Product name
- MDA 19
- Purity
- ≥95%
- Packaging
- 1mg
- Price
- $31
- Updated
- 2023/06/20
Cayman Chemical
- Product number
- 10563
- Product name
- MDA 19
- Purity
- ≥95%
- Packaging
- 5mg
- Price
- $128
- Updated
- 2023/06/20
Cayman Chemical
- Product number
- 10563
- Product name
- MDA 19
- Purity
- ≥95%
- Packaging
- 10mg
- Price
- $180
- Updated
- 2023/06/20
Cayman Chemical
- Product number
- 10563
- Product name
- MDA 19
- Purity
- ≥95%
- Packaging
- 50mg
- Price
- $670
- Updated
- 2023/06/20
Tocris
- Product number
- 4205
- Product name
- MDA19
- Purity
- ≥99%(HPLC)
- Packaging
- 25
- Price
- $292
- Updated
- 2021/12/16
More
Less
MDA 19 Chemical Properties,Usage,Production
Uses
MDA 19 is a selective agonist of the human peripheral cannabinoid (CB2) receptor. A cell-based functional assay showed MDA is an inverse agonist of the CB2 receptor in rat. Acts as an inverse agonist at the rat CB2 receptor. Reported Ki values are 16.3 and 1130 nM for human CB2 and CB1 receptor respectively. MDA19 was effective in attenuating tactile allodynia in neuropathic rats. MDA19 thus has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system.Synthetic Cannabinoids
MDA 19 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
MDA 19 Suppliers
1048973-47-2, MDA 19Related Search:
2-Nitro-4-methylsulfonylbenzoic acid
2,6-Dihydroxybenzoic acid
4-Methylsulphonylbenzoic acid
3,5-Dihydroxybenzoic acid